SPHK1 and cancer: Western blot analysis showed that incubation of resveratrol-pretreated cells with DMS and fingolimod did not cause changes in the enzyme expression, although both of them induced additional downregulation of SK1 activity (Figure 8B), which is an important finding, especially for cancer cells.